Dronabinol, a cannabinoid agonist, reduces hair pulling in trichotillomania: A pilot study

Psychopharmacology

Volumn 218, Issue 3, 2011, Pages 493-502

  Grant, Jon E ^a   Odlaug, Brian L ^a   Chamberlain, Samuel R ^b   Kim, Suck Won ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Cannabinoid; CANTAB; CB1; CB2; Cognition; Impulsivity

Indexed keywords

DRONABINOL;

ABDOMINAL PAIN; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITION; CONSTIPATION; DIZZINESS; DOSE RESPONSE; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG EFFECT; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; MASSACHUSETTS GENERAL HOSPITAL HAIR PULLING SCALE; NAUSEA AND VOMITING; NONVERBAL COMMUNICATION; OPEN STUDY; PARANOIA; PILOT STUDY; PRIORITY JOURNAL; RATING SCALE; SEDATION; SIDE EFFECT; TRICHOTILLOMANIA; UNSPECIFIED SIDE EFFECT; WEIGHT REDUCTION; XEROSTOMIA;

ADULT; COGNITION; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PILOT PROJECTS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTROPIC DRUGS; RECEPTORS, CANNABINOID; TETRAHYDROCANNABINOL; TREATMENT OUTCOME; TRICHOTILLOMANIA; YOUNG ADULT;

EID: 82955249255     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-011-2347-8     Document Type: Article

References (67)

1. American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders, 4th edn. American Psychiatric Association, Washington, D.C., text revision
2. AR Aron TW Robbins RA Poldrack 2004 Inhibition and the right inferior frontal cortex Trends Cogn Sci 8 170 177 15050513 10.1016/j.tics.2004.02.010 (Pubitemid 38429927)
3. JE Beal R Olson L Laubenstein JO Morales P Bellman B Yangco L Lefkowitz TF Plasse KV Shepard 1995 Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS J Pain Symptom Manage 10 89 97 7730690 10.1016/0885-3924(94)00117-4 1:STN:280:DyaK2M3kvVWluw%3D%3D
4. JE Beal R Olson L Lefkowitz L Laubenstein P Bellman B Yangco JO Morales R Murphy W Powderly TF Plasse KW Mosdell KV Shepard 1997 Long-term efficacy and safety of dronabinol for acquired immunodeficiency syndrome-associated anorexia J Pain Symptom Manage 14 7 14 9223837 10.1016/S0885-3924(97)00038-9 1:STN:280:DyaK2szmslSntA%3D%3D (Pubitemid 27287406)
5. C Benito JP Romero RM Tolón D Clemente F Docagne CJ Hillard C Guaza J Romero 2007 Cannabinoid CB1 and CB2 receptors and fatty acid amide hydrolase are specific markers of plaque cell subtypes in human multiple sclerosis J Neurosci 27 2396 2402 17329437 10.1523/JNEUROSCI.4814-06.2007 1:CAS:528:DC%2BD2sXjsVymsLY%3D (Pubitemid 46340977)
6. OJ Bienvenu Y Wang YY Shugart, et al. 2009 Sapap3 and pathological grooming in humans: results from the OCD collaborative genetics study Am J Med Genet B Neuropsychiatr Genet 150B 710 720 19051237 10.1002/ajmg.b.30897 1:CAS:528:DC%2BD1MXovFaqtr4%3D
7. SR Calhoun GP Galloway DE Smith 1998 Abuse potential of dronabinol (Marinol) J Psychoactive Drugs 30 2 187 196 9692381 10.1080/02791072.1998. 10399689 1:STN:280:DyaK1czlsFWjuw%3D%3D
8. Cambridge Cognition Limited (2006) CANTABeclipse, version 3. Cambridge Cognition Limited, Cambridge
9. SR Chamberlain BJ Sahakian 2007 The neuropsychiatry of impulsivity Curr Opin Psychiatry 20 255 261 17415079 (Pubitemid 46588298)
10. SR Chamberlain A Hampshire LA Menzies E Garyfallidis JE Grant BL Odlaug K Craig N Fineberg BJ Sahakian 2010 Reduced brain white matter integrity in trichotillomania: a diffusion tensor imaging study Arch Gen Psychiatry 67 965 971 20819990 10.1001/archgenpsychiatry.2010.109
11. Chamberlain SR, Robbins TW, Winder-Rhodes S, Müller U, Sahakian BJ, Blackwell AD, Barnett JH (2010b). Translational approaches to frontostriatal dysfunction in attention-deficit/hyperactivity disorder using a computerized neuropsychological battery. Biol Psychiatry. doi: 10.1016/j.biopsych.2010.08.019
12. Christenson GA, Mansueto CS (1999) Trichotillomania: descriptive characteristics and phenomenology. In: Stein DJ, Christianson GA, Hollander E (eds) Trichotillomania. American Psychiatric Press, Washington, D.C., pp 1-41
13. GA Christenson TB Mackenzie JE Mitchell 1991 Characteristics of 60 adult chronic hair pullers Am J Psychiatry 148 365 370 1992841 1:STN:280: DyaK3M7islOnuw%3D%3D
14. GA Christenson TB Mackenzie JE Mitchell AL Callies 1991 A placebo-controlled, double-blind crossover study of fluoxetine in trichotillomania Am J Psychiatry 148 1566 1571 1928474 1:STN:280: DyaK38%2Fis1Grug%3D%3D
15. L Clark 2010 Decision-making during gambling: an integration of cognitive and psychobiological approaches Philos Trans R Soc Lond B Biol Sci 365 319 330 20026469 10.1098/rstb.2009.0147
16. L Clark A Bechara H Damasio MR Aitken BJ Sahakian TW Robbins 2008 Differential effects of insular and ventromedial prefrontal cortex lesions on risky decision-making Brain 131 1311 1322 18390562 10.1093/brain/awn066 1:STN:280:DC%2BD1c3oslykug%3D%3D
17. V De Chiara F Angelucci S Rossi, et al. 2010 Brain-derived neurotrophic factor controls cannabinoid CB1 receptor function in the striatum J Neurosci 30 8127 8137 20554863 10.1523/JNEUROSCI.1683-10.2010
18. GJ Diefenbach DF Tolin S Hannan N Maltby J Crocetto 2006 Group treatment for trichotillomania: behavior therapy versus supportive therapy Behav Ther 37 353 363 17071213 10.1016/j.beth.2006.01.006 (Pubitemid 44634391)
19. DD Dougherty R Loh MA Jenike NJ Keuthen 2006 Single modality versus dual modality treatment for trichotillomania: sertraline, behavioral therapy, or both? J Clin Psychiatry 67 1086 1092 16889452 10.4088/JCP.v67n0711 1:CAS:528:DC%2BD28XoslGisL0%3D (Pubitemid 44230880)
20. G Dumont J van Hasselt M de Kam J van Gerven T Dj J Buitelaar R Verkes 2011 Acute psychomotor, memory and subjective effects of MDMA and THC co-administration over time in healthy volunteers J Psychopharmacol 25 478 489 20817749 10.1177/0269881110376687 1:CAS:528:DC%2BC3MXlt1Witb8%3D
21. First MB, Spitzer RL, Gibbon M, Williams JBW (1995) Structured Clinical Interview for DSM-IV-Patient Edition (SCID-I/P, Version 2.0). Biometrics Research Department, New York State Psychiatric Institute, New York
22. CA Flessner DW Woods ME Franklin SE Cashin NJ Keuthen Trichotillomania Learning Center-Scientific Advisory Board (TLC-SAB) 2008 The Milwaukee Inventory for Subtypes of Trichotillomania-Adult Version (MIST-A): development, exploratory factor analysis, and psychometric properties J Psychopathol Behav Assess 30 20 30 10.1007/s10862-007-9073-x
23. MB Frisch J Cornell M Villaneuva 1993 Clinical validation of the quality of life inventory: a measure of life satisfaction for use in treatment planning and outcome assessment Psychol Assess 4 92 101 10.1037/1040-3590.4.1.92
24. KM Gadde H Ryan Wagner 2nd KM Connor MS Foust 2007 Escitalopram treatment of trichotillomania Int Clin Psychopharmacol 22 39 42 17159458 10.1097/01.yic.0000224799.59524.50 (Pubitemid 44950766)
25. GL Gerdeman J Ronesi DM Lovinger 2002 Postsynaptic endocannabinoid release is critical to long-term depression in the striatum Nat Neurosci 5 446 451 11976704 1:CAS:528:DC%2BD38XjtFyktbc%3D (Pubitemid 34454250)
26. M Glass CC Felder 1997 Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: evidence for a Gs linkage to the CB1 receptor J Neurosci 17 5327 5333 9204917 1:CAS:528:DyaK2sXksVSgurw%3D
27. JE Grant BL Odlaug SW Kim 2009 N-acetylcysteine, a glutamate modulator, in the treatment of trichotillomania: a double-blind, placebo-controlled study Arch Gen Psychiatry 66 756 763 19581567 10.1001/archgenpsychiatry.2009.60 1:CAS:528:DC%2BD1MXptFGksL8%3D
28. Guy W (1976) ECDEU Assessment Manual for Psychopharmacology. US Dept Health, Education and Welfare publication (ADM). National Institute of Mental Health, Rockville, pp 76-338
29. M Hamilton 1959 The assessment of anxiety states by rating Br J Med Psychol 32 50 55 13638508 10.1111/j.2044-8341.1959.tb00467.x 1:STN:280:DyaG1M%2FmvVWisQ%3D%3D
30. M Hamilton 1960 A rating scale for depression J Neurol Neurosurg Psychiatry 23 56 62 14399272 10.1136/jnnp.23.1.56 1:STN:280:DyaF3c7ltFyksw%3D%3D
31. M Herkenham AB Lynn MD Little MR Johnson LS Melvin BR de Costa KC Rice 1990 Cannabinoid receptor localization in brain Proc Natl Acad Sci USA 87 1932 1936 2308954 10.1073/pnas.87.5.1932 1:CAS:528:DyaK3cXhsFWktLs%3D
32. CC Hunault TT Mensinga KB Böcker CM Schipper M Kruidenier ME Leenders I de Vries J Meulenbelt 2009 Cognitive and psychomotor effects in males after smoking a combination of tobacco and cannabis containing up to 69 mg delta-9-tetrahydrocannabinol (THC) Psychopharmacology (Berl) 204 85 94 10.1007/s00213-008-1440-0 1:CAS:528:DC%2BD1cXhsFWrt7zF
33. G Jager NF Ramsey 2008 Long-term consequences of adolescent cannabis exposure on the development of cognition, brain structure and function: an overview of animal and human research Curr Drug Abuse Rev 1 114 123 19630711 10.2174/1874473710801020114 1:CAS:528:DC%2BD1cXntFCrs78%3D
34. NJ Keuthen RL O'Sullivan JN Ricciardi D Shera CR Savage AS Borgmann MA Jenike L Baer 1995 The Massachusetts General Hospital (MGH) Hairpulling Scale: 1. Development and factor analyses Psychother Psychosom 64 141 145 8657844 10.1159/000289003 1:STN:280:DyaK283ksFOrtw%3D%3D
35. NJ Keuthen CA Flessner DW Woods ME Franklin DJ Stein SE Cashin Trichotillomania Learning Center Scientific Advisory Board 2007 Factor analysis of the Massachusetts General Hospital Hairpulling Scale J Psychosom Res 62 707 709 17540230 10.1016/j.jpsychores.2006.12.003 (Pubitemid 46809911)
36. NJ Keuthen BO Rothbaum MJ Falkenstein S Meunier KR Timpano MA Jenike SS Welch 2011 DBT-enhanced habit reversal treatment for trichotillomania: 3- and 6-month follow-up results Depress Anxiety 28 310 313 21456040 10.1002/da.20778
37. LG Khaspekov MS Brenz Verca LE Frumkina H Hermann G Marsicano B Lutz 2004 Involvement of brain-derived neurotrophic factor in cannabinoid receptor-dependent protection against excitotoxicity Eur J Neurosci 19 1691 1698 15078543 10.1111/j.1460-9568.2004.03285.x (Pubitemid 38482557)
38. LM Koran A Ringold W Hewlett 1992 Fluoxetine for trichotillomania: an open clinical trial Psychopharmacol Bull 28 145 149 1513916 1:STN:280: DyaK38zotlelsg%3D%3D
39. Lezak MD, Howieson DB, Loring DW et al (2004) Neuropsychological Assessment. Oxford University Press, New York
40. GD Logan WB Cowan KA Davis 1984 On the ability to inhibit simple and choice reaction time responses: a model and a method J Exp Psychol Hum Percept Perform 10 276 291 6232345 10.1037/0096-1523.10.2.276 1:STN:280: DyaL2c7oslCnsA%3D%3D
41. P Mailleux JJ Vanderhaeghen 1992 Localization of cannabinoid receptor in the human developing and adult basal ganglia. Higher levels in the striatonigral neurons Neurosci Lett 148 173 176 1300492 10.1016/0304-3940(92)90832-R 1:CAS:528:DyaK3sXlt1eksQ%3D%3D (Pubitemid 23007732)
42. F Manes B Sahakian L Clark R Rogers N Antoun M Aitken T Robbins 2002 Decision-making processes following damage to the prefrontal cortex Brain 125 624 639 11872618 10.1093/brain/awf049 (Pubitemid 34194416)
43. G Marsicano S Goodenough K Monory, et al. 2003 CB1 cannabinoid receptors and on-demand defense against excitotoxicity Science 302 84 88 14526074 10.1126/science.1088208 1:CAS:528:DC%2BD3sXnslSjs78%3D (Pubitemid 37210691)
44. PD Morrison V Zois DA McKeown TD Lee DW Holt JF Powell S Kapur RM Murray 2009 The acute effects of synthetic intravenous Delta9-tetrahydrocannabinol on psychosis, mood and cognitive functioning Psychol Med 39 1607 1616 19335936 10.1017/S0033291709005522 1:STN:280:DC%2BD1MnhtFKksA%3D%3D
45. KR Müller-Vahl H Kolbe U Schneider HM Emrich 1998 Cannabinoids: possible role in patho-physiology and therapy of Gilles de la Tourette syndrome Acta Psychiatr Scand 98 502 506 9879795 10.1111/j.1600-0447.1998.tb10127.x (Pubitemid 28566304)
46. KR Müller-Vahl U Schneider A Koblenz M Jöbges H Kolbe T Daldrup HM Emrich 2002 Treatment of Tourette's syndrome with Delta 9- tetrahydrocannabinol (THC): a randomized crossover trial Pharmacopsychiatry 35 57 61 11951146 10.1055/s-2002-25028 (Pubitemid 34293234)
47. PT Ninan B Knight L Kirk BO Rothbaum J Kelsey CB Nemeroff 1998 A controlled trial of venlafaxine in trichotillomania: interim phase I results Psychopharmacol Bull 34 221 224 9641004 1:CAS:528:DyaK1cXktF2lsL4%3D (Pubitemid 28292712)
48. BL Odlaug SW Kim JE Grant 2010 Quality of life and clinical severity in pathological skin picking and trichotillomania J Anxiety Disord 24 823 829 20594805 10.1016/j.janxdis.2010.06.004
49. AM Owen RG Morris BJ Sahakian CE Polkey TW Robbins 1996 Double dissociations of memory and executive functions in working memory tasks following frontal lobe excisions, temporal lobe excisions or amygdalo-hippocampectomy in man Brain 119 1597 1615 8931583 10.1093/brain/119.5. 1597 (Pubitemid 26375730)
50. RA Rabin KK Zakzanis TP George 2011 The effects of cannabis use on neurocognition in schizophrenia: a meta-analysis Schizophr Res 128 1-3 111 116 21420282 10.1016/j.schres.2011.02.017
51. JG Ramaekers MR Moeller P van Ruitenbeek EL Theunissen E Schneider G Kauert 2006 Cognition and motor control as a function of Delta9-THC concentration in serum and oral fluid: limits of impairment Drug Alcohol Depend 85 114 122 16723194 10.1016/j.drugalcdep.2006.03.015 1:CAS:528: DC%2BD28XhtVagtb7E (Pubitemid 44468137)
52. JG Ramaekers G Kauert EL Theunissen SW Toennes MR Moeller 2009 Neurocognitive performance during acute THC intoxication in heavy and occasional cannabis users J Psychopharmacol 23 266 277 18719045 10.1177/0269881108092393 1:CAS:528:DC%2BD1MXmvVOqtrg%3D
53. M Ranganathan DC D'Souza 2006 The acute effects of cannabinoids on memory in humans: a review Psychopharmacology (Berl) 188 425 444 10.1007/s00213-006- 0508-y 1:CAS:528:DC%2BD28XhtVeqsLnL (Pubitemid 44498214)
54. N Realini T Rubino D Parolaro 2009 Neurobiological alterations at adult age triggered by adolescent exposure to cannabinoids Pharmacol Res 60 132 138 19559364 10.1016/j.phrs.2009.03.006 1:CAS:528:DC%2BD1MXnvVWmsrk%3D
55. S Rossi V De Chiara A Musella H Kusayanagi G Mataluni G Bernardi A Usiello D Centonze 2008 Chronic psychoemotional stress impairs cannabinoid-receptor-mediated control of GABA transmission in the striatum J Neurosci 28 7284 7292 18632932 10.1523/JNEUROSCI.5346-07.2008 1:CAS:528:DC%2BD1cXovFWmt78%3D
56. BO Rothbaum PT Ninan 1994 The assessment of trichotillomania Behav Res Ther 32 651 662 8085996 10.1016/0005-7967(94)90022-1 1:STN:280: DyaK2czmvVartQ%3D%3D (Pubitemid 24173646)
57. Sheehan DV (1983) The anxiety disease. Scribner's, New York
58. DJ Stein C Bouwer CM Maud 1997 Use of the selective serotonin reuptake inhibitor citalopram in treatment of trichotillomania Eur Arch Psychiatry Clin Neurosci 247 234 236 9332906 10.1007/BF02900220 1:STN:280:DyaK2svnsVSltg%3D%3D (Pubitemid 27399828)
59. SM Streichenwein JI Thornby 1995 A long-term, double-blind, placebo-controlled crossover trial of the efficacy of fluoxetine for trichotillomania Am J Psychiatry 152 1192 1196 7625469 1:STN:280: DyaK2MzltFeqtQ%3D%3D
60. SE Swedo HL Leonard JL Rapoport MC Lenane EL Goldberger DL Cheslow 1989 A double-blind comparison of clomipramine and desipramine in the treatment of trichotillomania (hair pulling) N Engl J Med 321 497 501 2761586 10.1056/NEJM198908243210803 1:STN:280:DyaL1MzksVWmsQ%3D%3D (Pubitemid 19203873)
61. SE Swedo MC Lenane HL Leonard 1993 Long-term treatment of trichotillomania (hair pulling) N Engl J Med 329 141 142 8510704 10.1056/NEJM199307083290220 1:STN:280:DyaK3s3ovVSrsQ%3D%3D (Pubitemid 23188838)
62. DF Tolin ME Franklin GJ Diefenbach E Anderson SA Meunier 2007 Pediatric trichotillomania: descriptive psychopathology and an open trial of cognitive behavioral therapy Cogn Behav Ther 36 129 144 17852170 10.1080/16506070701223230 (Pubitemid 47604685)
63. M Van Ameringen C Mancini B Patterson M Bennett J Oakman 2010 A randomized, double-blind, placebo-controlled trial of olanzapine in the treatment of trichotillomania J Clin Psychiatry 71 1336 1343 20441724 10.4088/JCP.09m05114gre
64. M van der Stelt V Di Marzo 2005 Cannabinoid receptors and their role in neuroprotection Neuromolecular Med 7 37 50 16052037 10.1385/NMM:7:1-2:037 (Pubitemid 41278188)
65. RM Winchel JS Jones B Stanley A Molcho M Stanley 1992 Clinical characteristics of trichotillomania and its response to fluoxetine J Clin Psychiatry 53 304 308 1517191 1:STN:280:DyaK38zovVSktg%3D%3D
66. DW Woods CT Wetterneck CA Flessner 2006 A controlled evaluation of acceptance and commitment therapy plus habit reversal for trichotillomania Behav Res Ther 44 639 656 16039603 10.1016/j.brat.2005.05.006
67. DW Woods CA Flessner ME Franklin NJ Keuthen RD Goodwin DJ Stein MR Walther Trichotillomania Learning Center-Scientific Advisory Board 2006 The Trichotillomania Impact Project (TIP): exploring phenomenology, functional impairment, and treatment utilization J Clin Psychiatry 67 1877 1888 17194265 10.4088/JCP.v67n1207 (Pubitemid 46048185)